KOR

e-Article

EBSCO Discovery Service
Publication date
-
(ex : 2010-2015)
전자자료 공정이용 안내

우리 대학 도서관에서 구독·제공하는 모든 전자자료(데이터베이스, 전자저널, 전자책 등)는 국내외 저작권법과 출판사와의 라이선스 계약에 따라 엄격하게 보호를 받고 있습니다.
전자자료의 비정상적 이용은 출판사로부터의 경고, 서비스 차단, 손해배상 청구 등 학교 전체에 심각한 불이익을 초래할 수 있으므로, 아래의 공정이용 지침을 반드시 준수해 주시기 바랍니다.

공정이용 지침
  • 전자자료는 개인의 학습·교육·연구 목적의 비영리적 사용에 한하여 이용할 수 있습니다.
  • 합리적인 수준의 다운로드 및 출력만 허용됩니다. (일반적으로 동일 PC에서 동일 출판사의 논문을 1일 30건 이하 다운로드할 것을 권장하며, 출판사별 기준에 따라 다를 수 있습니다.)
  • 출판사에서 제공한 논문의 URL을 수업 관련 웹사이트에 게재할 수 있으나, 출판사 원문 파일 자체를 복제·배포해서는 안 됩니다.
  • 본인의 ID/PW를 타인에게 제공하지 말고, 도용되지 않도록 철저히 관리해 주시기 바랍니다.
불공정 이용 사례
  • 전자적·기계적 수단(다운로딩 프로그램, 웹 크롤러, 로봇, 매크로, RPA 등)을 이용한 대량 다운로드
  • 동일 컴퓨터 또는 동일 IP에서 단시간 내 다수의 원문을 집중적으로 다운로드하거나, 전권(whole issue) 다운로드
  • 저장·출력한 자료를 타인에게 배포하거나 개인 블로그·웹하드 등에 업로드
  • 상업적·영리적 목적으로 자료를 전송·복제·활용
  • ID/PW를 타인에게 양도하거나 타인 계정을 도용하여 이용
  • EndNote, Mendeley 등 서지관리 프로그램의 Find Full Text 기능을 이용한 대량 다운로드
  • 출판사 콘텐츠를 생성형 AI 시스템에서 활용하는 행위(업로드, 개발, 학습, 프로그래밍, 개선 또는 강화 등)
위반 시 제재
  • 출판사에 의한 해당 IP 또는 기관 전체 접속 차단
  • 출판사 배상 요구 시 위반자 개인이 배상 책임 부담
'e-Article' searched 52results | List 1~20
Academic Journal
Capdevila J; Department of Medical Oncology, Gastrointestinal and Endocrine Tumor Unit, Vall d'Hebron Hospital Universitari, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain; Neuroendocrine and Endocrine Tumor Translational Research Program (NET-VHIO), Vall Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.; Tafuto S; Sarcomas and Rare Tumors Unit, Istituto Nazionale Tumori IRCCS, Fondazione 'G.Pascale', Naples, Italy.; Krogh M; Medical Oncology Department, Odense University Hospital, Odense, Denmark.; Teulé A; Medical Oncology Department, Oncobell Program, IDIBELL, Institut Català d'Oncologia (ICO) Hospital Duran i Reynals, Barcelona, Spain; Clinical Sciences Department, Bellvitge Campus, University of Barcelona, CIBERONC, Barcelona, Spain.; Garcia-Carbonero R; Medical Oncology Department, Hospital Universitario 12 de Octubre, Imas12, UCM, Madrid, Spain.; Klümpen HJ; Medical Oncology Department, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.; Cremer B; Medical Oncology Department, Universitätsklinikum Köln (AöR), Köln, Germany.; Sevilla I; Medical Oncology Department, Investigación Clínica y Traslacional en Cáncer, Instituto de Investigaciones Biomédicas de Málaga (IBIMA), Hospital Universitario Virgen de la Victoria de Málaga, Málaga, Spain.; Eriksson B; Endocrine Oncology Department, Uppsala University Hospital, Uppsala, Sweden.; Tabaksblat E; Medical Oncology Department, Aarhus University Hospital, ENETS Center of Excellence, Aarhus, Denmark.; Metges JP; Medical Oncology Department, Brest Hôpital Augustin Morvan, Institut de Cancero-Hemato, Brest, France.; Reed NS; Medical Oncology Department, Beatson Oncology Centre, Glasgow, UK.; Schrader J; Medical Oncology Department, Hamburg Medizinische Klinik und Poliklinik, Universitätsklinikum Hamburg-Eppendorf, Hamburg, Germany.; Navarro V; Clinical Research Unit, Institut Català d'Oncologia (ICO), L'Hospitalet de Llobregat, Barcelona, Spain.; Valentí V; Medical Oncology Department, Oncobell Program, IDIBELL, Institut Català d'Oncologia (ICO) Hospital Duran i Reynals, Barcelona, Spain; Clinical Sciences Department, Bellvitge Campus, University of Barcelona, CIBERONC, Barcelona, Spain.; Hernando J; Department of Medical Oncology, Gastrointestinal and Endocrine Tumor Unit, Vall d'Hebron Hospital Universitari, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain; Neuroendocrine and Endocrine Tumor Translational Research Program (NET-VHIO), Vall Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.; Colao AM; Sarcomas and Rare Tumors Unit, Istituto Nazionale Tumori IRCCS, Fondazione 'G.Pascale', Naples, Italy.; Vestermark L; Medical Oncology Department, Odense University Hospital, Odense, Denmark.; Carnaghi C; Medical Oncology Department, Humanitas Cancer Center, Milano, Italy.; Knigge UP; Department of Endocrinology, ENETS Center of Excellence, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.; Jimenez-Fonseca P; Medical Oncology Department, Hospital Universitario Central de Asturias, ISPA, Oviedo, Spain.; Benavent M; Medical Oncology Department, University Hospital Virgen del Rocío, Seville Institute of Biomedicine (IBIS), Seville, Spain.; de Vos-Geelen J; Medical Oncology Department, GROW - Research Institute for Oncology & Reproduction, Maastricht University Medical Centre, Maastricht, The Netherlands.; Venerito M; Department of Gastroenterology, Hepatology and Infectious Diseases, Universitätsklinikum Magdeburg A. ö. R, Magdeburg, Germany.; Von Werder A; Medical Oncology Department, München rechts der Isar II, Medizinische Klinik und Poliklinik, München, Germany.; Jann H; Medical Oncology Department, Berlin Charité Universitätsmedizin, Berlin, Germany.; Rinke A; Department of Gastroenterology, Marburg Universitätsklinikum Giessen und Marburg, Marburg, Germany; Philipps University Marburg, Marburg, Germany.; Smith D; Medical Oncology Department, Bordeaux University Hospital-CHU Bordeaux, Hôpital Saint-André, Bordeaux, France.; Hörsch D; Medical Oncology Department, Bad Berka ChA Klinik für Innere Medizin, Bad Berka, Germany.; Starling N; Medical Oncology Department, The Royal Marsden NHS Foundation Trust, Sutton, UK.; Ruszniewski P; Medical Oncology Department, Université Paris Cité, Beaujon Hospital, APHP, Clichy, France.; Baudin E; Medical Oncology Department, Villejuif Institut Gustave-Roussy, Paris, France.; Caroli-Bosc FX; Medical Oncology Department, Unité Transversale de Thérapeutiques Innovantes en Oncologie Médicale (UTTIOM), Centre Hospitalier Universitaire (CHU) Angers, Angers, France.; Manzano JL; Medical Oncology Department, Institut Català d'Oncologia (ICO), ICO-Badalona, H. Germans Trias i Pujol, Badalona, Barcelona, Spain.; Martín M; Medical Oncology Department, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.; Scarpa A; ARC-Net Research Center, University and Hospital Trust of Verona, Verona, Italy; Department of Diagnostics and Public Health, Section of Pathology, and Department of Engineering for Innovative Medicine, University of Verona, Verona, Italy.; Lawlor RT; ARC-Net Research Center, University and Hospital Trust of Verona, Verona, Italy; Department of Diagnostics and Public Health, Section of Pathology, and Department of Engineering for Innovative Medicine, University of Verona, Verona, Italy.; Ragulan C; Division of Molecular Pathology, Institute of Cancer Research, London, UK.; Ps H; Division of Molecular Pathology, Institute of Cancer Research, London, UK.; Sadanandam A; Division of Molecular Pathology, Institute of Cancer Research, London, UK.; Carmona-Bayonas A; Medical Oncology Department, Hospital General Universitario Morales Meseguer, UMU, IMIB, Murcia, Spain.; Salazar R; Medical Oncology Department, Oncobell Program, IDIBELL, Institut Català d'Oncologia (ICO) Hospital Duran i Reynals, Barcelona, Spain; Clinical Sciences Department, Bellvitge Campus, University of Barcelona, CIBERONC, Barcelona, Spain. Electronic address: ramonsalazar@iconcologia.net.
Publisher: Elsevier Country of Publication: England NLM ID: 101690685 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2059-7029 (Electronic) Linking ISSN: 20597029 NLM ISO Abbreviation: ESMO Open Subsets: MEDLINE
Conference
Journal of Neuroendocrinology
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
Institut de Recerca Germans Trias i Pujol (IGTP)
Conference
European Journal of Human Genetics
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
Institut de Recerca Germans Trias i Pujol (IGTP)
Conference
ANNALS OF ONCOLOGY
r-FISABIO. Repositorio Institucional de Producción Científica
Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (FISABIO)
Annals of Oncology
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
Institut de Recerca Germans Trias i Pujol (IGTP)
Conference
JOURNAL OF CLINICAL ONCOLOGY
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
Institut de Recerca Germans Trias i Pujol (IGTP)
Academic Journal
Capdevila J; Medical Oncology Department, Vall Hebron University Hospital, Vall Hebron Institute of Oncology (VHIO), Barcelona, Spain. jcapdevila@vhio.net.; Medical Oncology Department, IOB-Quiron-Teknon, Barcelona, Spain. jcapdevila@vhio.net.; Hernando J; Medical Oncology Department, Vall Hebron University Hospital, Vall Hebron Institute of Oncology (VHIO), Barcelona, Spain.; Teule A; Medical Oncology Department, Institut Català d'Oncologia (ICO) - IDIBELL L'Hospitalet del Llobregat, L'Hospitalet de Llobregat, Spain.; Lopez C; Medical Oncology Department, Hospital Universitario Marqués de Valdecilla, IDIVAL, Santander, Spain.; Garcia-Carbonero R; Medical Oncology Department, Hospital Universitario 12 de Octubre, Imas12, UCM, CNIO, Madrid, Spain.; Benavent M; Medical Oncology Department, University Hospital Virgen del Rocío, Instituto de Biomedicina de Sevilla (IBIS), Seville, Spain.; Custodio A; Medical Oncology Department, Hospital Universitario La Paz, Madrid, Spain.; Garcia-Alvarez A; Medical Oncology Department, Vall Hebron University Hospital, Vall Hebron Institute of Oncology (VHIO), Barcelona, Spain.; Cubillo A; Medical Oncology Department, Hospital Universitario HM Sanchinarro, Madrid, Spain.; Alonso V; Medical Oncology Department, Hospital Universitario Miguel Servet, Instituto de Investigación Sanitaria de Aragón (IISA), Zaragoza, Spain.; Carmona-Bayonas A; Hematology and Medical Oncology Department, Hospital Universitario Morales Meseguer, UMU, IMIB, Murcia, Spain.; Alonso-Gordoa T; Medical Oncology, Hospital Universitario Ramón y Cajal, Madrid, Spain.; Crespo G; Medical Oncology Department, Complejo Asistencial Universitario de Burgos, Burgos, Spain.; Jimenez-Fonseca P; Medical Oncology Department, Hospital Universitario Central de Asturias, ISPA, Oviedo, Spain.; Blanco M; Medical Oncology Department, Hospital Universitario Gregorio Marañon, Madrid, Spain.; Viudez A; Medical Oncology Department, Hospital Universitario de Navarra, Pamplona, Spain.; La Casta A; Medical Oncology Department, Hospital Universitario Donostia, San Sebastián, Spain.; Sevilla I; Medical Oncology Department, Investigación Clínica y Traslacional en Cáncer/Instituto de Investigaciones Biomédicas de Málaga (IBIMA)/Hospitales Universitarios Regional y Virgen de la Victoria de Málaga, Málaga, Spain.; Segura A; Medical Oncology Department, Hospital Universitario y Politécnico La Fe, Valencia, Spain.; Llanos M; Medical Oncology Department, Hospital Universitario de Canarias, San Cristobal de la Laguna, Spain.; Landolfi S; Pathology Department, Vall Hebron University Hospital, CIBERONC, Barcelona, Spain.; Nuciforo P; Molecular Oncology Group. Vall Hebron Institute of Oncology (VHIO), Barcelona, Spain.; Manzano JL; Medical Oncology Department, Institut Català d'Oncologia (ICO) - Badalona, Hospital Germans Trias i Pujol, Badalona, Spain.
Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE
Academic Journal
Annals of Oncology
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
instname
ANNALS OF ONCOLOGY
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
Instituto de Investigación Sanitaria La Fe (IIS La Fe)
Repisalud
Instituto de Salud Carlos III (ISCIII)
Institut de Recerca Germans Trias i Pujol (IGTP)
Academic Journal
JOURNAL OF CLINICAL ONCOLOGY
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
Institut de Recerca Germans Trias i Pujol (IGTP)
Conference
Journal of Neuroendocrinology
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
Institut de Recerca Germans Trias i Pujol (IGTP)
instname
Conference
Annals of Oncology
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
Institut de Recerca Germans Trias i Pujol (IGTP)
instname
Conference
Annals of Oncology
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
Institut de Recerca Germans Trias i Pujol (IGTP)
instname
Conference
Annals of Oncology
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
Institut de Recerca Germans Trias i Pujol (IGTP)
Academic Journal
Mosteiro M; Department of Medical Oncology, Catalan Institute of Oncology (ICO), L'Hospitalet del Llobregat, Barcelona, Spain; Preclinical and Experimental Research in Thoracic Tumors (PReTT), Molecular Mechanisms and Experimental Therapy in Oncology Program (Oncobell), Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, Barcelona, Spain.; Azuara D; Laboratory Core Molecular Analysis (L-CAM), Hospital Universitari de Bellvitge and Catalan Institute of Oncology, L'Hospitalet del Llobregat, Barcelona, Spain; Hereditary Cancer Program, Molecular Mechanisms and Experimental Therapy in Oncology (Oncobell) Program, Catalan Institute of Oncology (ICO), Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet del Llobregat, Barcelona, Spain.; Villatoro S; Laboratory Core Molecular Analysis (L-CAM), Hospital Universitari de Bellvitge and Catalan Institute of Oncology, L'Hospitalet del Llobregat, Barcelona, Spain; Department of Pathology, Hospital Universitari de Bellvitge and Catalan Institute of Oncology (ICO), L'Hospitalet del Llobregat, Barcelona, Spain.; Alay A; Preclinical and Experimental Research in Thoracic Tumors (PReTT), Molecular Mechanisms and Experimental Therapy in Oncology Program (Oncobell), Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, Barcelona, Spain; Unit of Bioinformatics for Precision Oncology (UBOP), Catalan Institute of Oncology (ICO), L'Hospitalet de Llobregat, Barcelona, Spain.; Gausachs M; Department of Medical Oncology, Catalan Institute of Oncology (ICO), L'Hospitalet del Llobregat, Barcelona, Spain; Preclinical and Experimental Research in Thoracic Tumors (PReTT), Molecular Mechanisms and Experimental Therapy in Oncology Program (Oncobell), Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, Barcelona, Spain.; Varela M; Laboratory Core Molecular Analysis (L-CAM), Hospital Universitari de Bellvitge and Catalan Institute of Oncology, L'Hospitalet del Llobregat, Barcelona, Spain; Department of Pathology, Hospital Universitari de Bellvitge and Catalan Institute of Oncology (ICO), L'Hospitalet del Llobregat, Barcelona, Spain.; Baixeras N; Department of Pathology, Hospital Universitari de Bellvitge and Catalan Institute of Oncology (ICO), L'Hospitalet del Llobregat, Barcelona, Spain.; Pijuan L; Department of Pathology, Hospital Universitari de Bellvitge and Catalan Institute of Oncology (ICO), L'Hospitalet del Llobregat, Barcelona, Spain.; Ajenjo-Bauza M; Unit of Bioinformatics for Precision Oncology (UBOP), Catalan Institute of Oncology (ICO), L'Hospitalet de Llobregat, Barcelona, Spain.; Lopez-Doriga A; Preclinical and Experimental Research in Thoracic Tumors (PReTT), Molecular Mechanisms and Experimental Therapy in Oncology Program (Oncobell), Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, Barcelona, Spain; Unit of Bioinformatics for Precision Oncology (UBOP), Catalan Institute of Oncology (ICO), L'Hospitalet de Llobregat, Barcelona, Spain; Centro de Investigación Biomédica en Red de Epidemiologia y Salud Pública (CIBERESP), Madrid, Spain.; Teulé Á; Department of Medical Oncology, Catalan Institute of Oncology (ICO), L'Hospitalet del Llobregat, Barcelona, Spain; Hereditary Cancer Program, Molecular Mechanisms and Experimental Therapy in Oncology (Oncobell) Program, Catalan Institute of Oncology (ICO), Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet del Llobregat, Barcelona, Spain.; Solanes A; Department of Medical Oncology, Catalan Institute of Oncology (ICO), L'Hospitalet del Llobregat, Barcelona, Spain; Hereditary Cancer Program, Molecular Mechanisms and Experimental Therapy in Oncology (Oncobell) Program, Catalan Institute of Oncology (ICO), Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet del Llobregat, Barcelona, Spain.; Palmero R; Department of Medical Oncology, Catalan Institute of Oncology (ICO), L'Hospitalet del Llobregat, Barcelona, Spain; Preclinical and Experimental Research in Thoracic Tumors (PReTT), Molecular Mechanisms and Experimental Therapy in Oncology Program (Oncobell), Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, Barcelona, Spain.; Brenes J; Department of Medical Oncology, Catalan Institute of Oncology (ICO), L'Hospitalet del Llobregat, Barcelona, Spain; Preclinical and Experimental Research in Thoracic Tumors (PReTT), Molecular Mechanisms and Experimental Therapy in Oncology Program (Oncobell), Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, Barcelona, Spain.; Jové M; Department of Medical Oncology, Catalan Institute of Oncology (ICO), L'Hospitalet del Llobregat, Barcelona, Spain; Preclinical and Experimental Research in Thoracic Tumors (PReTT), Molecular Mechanisms and Experimental Therapy in Oncology Program (Oncobell), Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, Barcelona, Spain.; Padrones S; Department of Respiratory Medicine, Hospital Universitari de Bellvitge, L'Hospitalet del Llobregat, Barcelona, Spain.; Moreno V; Centro de Investigación Biomédica en Red de Epidemiologia y Salud Pública (CIBERESP), Madrid, Spain; Oncology Data Analytics Program, Catalan Institute of Oncology (ICO), Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, Barcelona, Spain; Department of Clinical Sciences, Faculty of Medicine, and Universitat de Barcelona Institute of Complex Systems (UBICS), University of Barcelona, Barcelona, Spain.; Cordero D; Preclinical and Experimental Research in Thoracic Tumors (PReTT), Molecular Mechanisms and Experimental Therapy in Oncology Program (Oncobell), Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, Barcelona, Spain; Department of Pathology, Hospital Universitari de Bellvitge and Catalan Institute of Oncology (ICO), L'Hospitalet del Llobregat, Barcelona, Spain; Unit of Bioinformatics for Precision Oncology (UBOP), Catalan Institute of Oncology (ICO), L'Hospitalet de Llobregat, Barcelona, Spain; Centro de Investigación Biomédica en Red de Epidemiologia y Salud Pública (CIBERESP), Madrid, Spain. Electronic address: dcordero@iconcologia.net.; Matías-Guiu X; Laboratory Core Molecular Analysis (L-CAM), Hospital Universitari de Bellvitge and Catalan Institute of Oncology, L'Hospitalet del Llobregat, Barcelona, Spain; Department of Pathology, Hospital Universitari de Bellvitge and Catalan Institute of Oncology (ICO), L'Hospitalet del Llobregat, Barcelona, Spain. Electronic address: xmatias@bellvitgehospital.cat.; Lázaro C; Laboratory Core Molecular Analysis (L-CAM), Hospital Universitari de Bellvitge and Catalan Institute of Oncology, L'Hospitalet del Llobregat, Barcelona, Spain; Hereditary Cancer Program, Molecular Mechanisms and Experimental Therapy in Oncology (Oncobell) Program, Catalan Institute of Oncology (ICO), Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet del Llobregat, Barcelona, Spain; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain. Electronic address: conxi.lazaro@gmail.com.; Nadal E; Department of Medical Oncology, Catalan Institute of Oncology (ICO), L'Hospitalet del Llobregat, Barcelona, Spain; Preclinical and Experimental Research in Thoracic Tumors (PReTT), Molecular Mechanisms and Experimental Therapy in Oncology Program (Oncobell), Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, Barcelona, Spain. Electronic address: esnadal@iconcologia.net.
Publisher: Elsevier Country of Publication: England NLM ID: 101690685 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2059-7029 (Electronic) Linking ISSN: 20597029 NLM ISO Abbreviation: ESMO Open Subsets: MEDLINE
Refining the search results
Facets
[AR] Teule, A
Publication year
-
Database provider
Title
Publisher
자료유형(Source Type)
Subject
Language